Naranjo Adverse Drug Reaction Scale
Standardised questionnaire to assess the probability that an adverse drug reaction (ADR) is caused by a specific drug
Score interpretation
Score ≤ 0: Unlikely to be a drug reaction.
→ Explore alternative diagnoses. Cautious re-challenge may be considered.
Score 1–4: Possible adverse drug reaction.
→ Document reaction. Review drug appropriateness. Monitor closely.
Score 5–8: Probable adverse drug reaction.
→ Discontinue or change offending drug. Report to Yellow Card (UK MHRA).
Score ≥ 9: Definite adverse drug reaction.
→ Discontinue drug immediately. Report Yellow Card. Document allergy/ADR clearly in notes.
Interpretation bands for the Naranjo ADR. Apply clinical judgement and local guidance.
References
- Naranjo CA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30(2):239–245.
Related
Curated clinical cross-links plus same-class fallbacks.
- Difficult Airway Algorithm (DAS) · DAS 2015; Royal College of Anaesthetists
- Major Haemorrhage Protocol · NICE NG24; UK MHP guidelines
- New-Onset Atrial Fibrillation · ESC 2020 AF Guidelines; NICE NG196
- Hypertensive Emergency · ESC/ESH 2018 Hypertension Guidelines; NICE NG136
- Bradycardia Management · Resuscitation Council UK ABCDE; ESC 2021 Pacing Guidelines
- Ventricular Tachycardia / Fibrillation · Resuscitation Council UK ACLS; ESC 2022 Ventricular Arrhythmia Guidelines
Featured in these MRCEM clinical pathways
The Naranjo ADR is covered in detail — with RCEM/NICE evidence base, indications and pitfalls — in the following exam-focused pathways on our sister siteReviseMRCEM.
MRCEM Primary / Intermediate / OSCE candidates: each pathway includes exam-style questions, RCEM/NICE citations, and FAQ summaries.
Decision support only — verify against a current formulary, NICE, or your local guideline before clinical use.